BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2001
View Archived Issues
2001 milestones highlighted by ImmunoGen
Read More
Antiallergic agent codeveloped by Tanabe Seiyaku and Ube licensed for Korean market
Read More
Almirall Prodesfarma granted exclusive rights to Japanese antipsychotic
Read More
Ariflo highlighted at ATS meeting as promising COPD therapy
Read More
In vitro and animal studies support further development of EPI-HNE-4 for CF
Read More
AlphaGene identifies novel CEA marker in prostate tissue
Read More
IPL-576092, a novel antiinflammatory agent, safe and well tolerated in phase I trials
Read More
Large phase III study to evaluate Aromasin following tamoxifen treatment for breast cancer
Read More
Joint venture created to manufacture and sell PG2 in China
Read More
Transplant 2001: immune function-suppressing effects of FK-778 investigated in primate lymphocytes
Read More
Hybrigenics and Institut Curie open laboratory for cancer proteomics research
Read More
Imiquimod under investigation for various dermatological conditions
Read More
Remune induces allo- and HIV-1-specific responses in phase II study
Read More
Company Profile: Big Bear Bio
Read More
Preliminary data support new EP4 agonist as potential treatment for acute liver failure
Read More
Biosyn obtains license to microbicidal compound for prevention of HIV infection
Read More
CAPE efficacy in rat model of colitis attributed to inhibition of NF-kB
Read More
Novactyl receives FDA approval to begin clinical trials of herpes labialis drug
Read More
Findings from first phase I clinical trial of Panzem presented at ASCO meeting
Read More
Revived hope for tesmilifene in breast cancer at YM BioSciences
Read More
Company Profile: GeneCure
Read More
Nonpeptide inhibitors of methionyl aminopeptidase useful for angiogenesis-related conditions
Read More
Sulfonamides designed at Banyu which act as ORL1 antagonists
Read More
Melatonin receptor ligands designed at ADIR
Read More
Potent PAI-1 inhibitors discovered by ADIR scientists
Read More
Tyrosine kinase inhibitors useful for immunological disorders and cancer
Read More
Novel antipsoriatic agents from AstraZeneca block the CXCR2 receptor
Read More
Novel antifungal agents presented by Japanese lab
Read More